CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹308 Cr | ₹240 Cr | ₹17 Cr | ₹235 Cr | ₹1,690 Cr |
What is the latest Consolidated Net Profit of CONCORD BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹308 Cr |
| Mar2024 | ₹240 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹235 Cr |
| Mar2021 | ₹1,690 Cr |
How is Consolidated Net Profit of CONCORD BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹308 Cr | 28.33 | |
| Mar2024 | ₹240 Cr | 1,272.47 | |
| Mar2023 | ₹17 Cr | -92.55 | |
| Mar2022 | ₹235 Cr | -86.10 | |
| Mar2021 | ₹1,690 Cr | - | |
Compare Consolidated Net Profit of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹10,675.5 Cr | -1.7% | -18.2% | -39.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.7% |
-18.2% |
-39.9% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses